Teva Pharmaceutical Industries Ltd. (TEVA) 30th Annual J.P. Morgan Healthcare Conference January 10, 2012 12:30 PM ET
Executives
Eyal Desheh - CFO William S. Marth - President & Chief Executive Officer Americas
Analysts
Chris Schott – JP Morgan
Presentation
[Q&A session only]
Question-And-Answer

Chris Schott – JP

Morgan
Great. Good morning, everybody. I’m Chris Schott, Pharmaceutical Analyst at JP Morgan. I’m very pleased to be introducing Teva this morning. From Teva we’ve Eyal Desheh, the company’s CFO, as well as Bill Marth, who is President and CEO of Teva Americas. We are going to do a format today, it’s going to be more kind of a Q&A type of format. But I was going to have Eyal make some quick opening remarks and I will go to kind of some interactive questions from there.
Eyal Desheh
Well, thank you very much. Good morning, everyone. We’re always happy to be hereComplete Story »